Qtern: Dapagliflozin + Saxagliptin Uses and Safety

Qtern (dapagliflozin + saxagliptin) is a prescription combination medicine used to help adults with type 2 diabetes control their blood sugar levels. It contains two medications that work differently: one helps the kidneys remove excess glucose, while the other supports the body's natural insulin response. This combination can improve blood sugar control when treatment with a single medicine is not enough. However, Qtern also carries important precautions involving kidney function, dehydration, infections, and heart failure. In 2026, the original Qtern brand is listed as discontinued in the United States, although FDA-approved generic combinations are available. This guide explains Qtern's uses, how it works, its benefits, side effects, and the safety precautions patients should understand.

What Is Qtern and What Is It Used For?
Qtern is an FDA-approved combination of dapagliflozin and saxagliptin used alongside diet and exercise to improve blood sugar control in adults with type 2 diabetes. Doctors may consider this combination when additional glucose-lowering treatment is appropriate.
Type 2 diabetes develops when the body cannot use insulin effectively or cannot produce enough insulin to maintain healthy blood sugar levels.
Over time, uncontrolled blood glucose can damage blood vessels, nerves, kidneys, and other organs.
The June 2026 FDA prescribing information for Qtern confirms its approved use and important safety restrictions.
Why do doctors prescribe two diabetes medicines together?
Different diabetes medicines target different processes involved in blood sugar regulation.
Combining medications can sometimes provide greater glucose reduction than using either medicine alone.
Qtern combines two ingredients in one tablet, potentially simplifying treatment for suitable patients.
However, it is not appropriate for everyone. Doctors consider blood sugar levels, kidney function, heart health, and other medications before prescribing it.
Is Qtern still available in the USA in 2026?
The original Qtern brand tablets are listed as discontinued in the United States.
Importantly, the FDA's determination about discontinued Qtern products confirms that these products were not withdrawn from sale for reasons of safety or effectiveness.
In April 2026, the FDA approved generic dapagliflozin-saxagliptin combination tablets.
The FDA's 2026 first generic drug approvals list identifies approvals for manufacturers including MSN Laboratories and Torrent Pharmaceuticals.
However, approval does not guarantee availability at every pharmacy. Patients should confirm current options with a licensed pharmacist.
How Do Dapagliflozin and Saxagliptin Work Together?
Qtern lowers blood sugar through two complementary mechanisms. Dapagliflozin increases the amount of glucose removed through urine, while saxagliptin helps the body regulate insulin and other hormones involved in blood sugar control.
This combination targets different causes of elevated blood glucose.
Dapagliflozin: Removing excess glucose through urine
Dapagliflozin belongs to a medicine class called SGLT2 inhibitors.
The kidneys normally filter glucose from the blood and return much of it to circulation.
Dapagliflozin blocks part of this process, allowing additional glucose to leave the body through urine.
This helps lower blood sugar.
However, increased glucose in urine can also contribute to genital infections, urinary infections, and increased urination.
Saxagliptin: Supporting insulin regulation
Saxagliptin belongs to a medicine class called DPP-4 inhibitors.
It works by slowing the breakdown of natural hormones released after eating.
These hormones help the pancreas release insulin when blood sugar is elevated and reduce excessive glucagon activity.
Glucagon is a hormone that signals the liver to release glucose.
Together, these effects help regulate blood sugar after meals.
How do the two ingredients compare?
Comparison of dapagliflozin and saxagliptin, their functions, and important safety considerations.
Feature | Dapagliflozin | Saxagliptin |
Drug class | SGLT2 inhibitor | DPP-4 inhibitor |
Main action | Removes excess glucose through urine | Supports natural insulin regulation |
Main benefit | Lowers blood sugar | Lowers blood sugar |
Weight effect | May produce modest weight reduction | Generally weight-neutral |
Common concerns | Increased urination, genital infections, urinary infections | Headache, respiratory symptoms, and other possible effects |
Serious risks | Ketoacidosis, dehydration, serious infections | Pancreatitis, heart failure warning, severe joint pain |
Both ingredients contribute to Qtern's overall effects. Their safety risks must be considered together.
What Are the Benefits of Qtern for Type 2 Diabetes?
Qtern can improve blood sugar control in suitable adults with type 2 diabetes, particularly when existing treatment is not achieving the desired result.
Its effectiveness is commonly measured using HbA1c, a blood test that reflects average blood sugar over approximately two to three months.
How effective is Qtern at reducing HbA1c?
A 24-week clinical study included adults whose type 2 diabetes was inadequately controlled with metformin.
Researchers compared dapagliflozin and saxagliptin together with metformin against treatment groups receiving only one of the additional medicines with metformin.
The average HbA1c reductions were:
Dapagliflozin + saxagliptin + metformin: 1.49 percentage points
Dapagliflozin + metformin: 1.23 percentage points
Saxagliptin + metformin: 1.00 percentage point
The combination produced greater average blood sugar improvement in this study.
However, these findings involved patients taking metformin and do not guarantee the same results for everyone.
Does Qtern help with weight loss?
Some patients may experience modest weight reduction because dapagliflozin increases glucose loss through urine.
However, Qtern is not approved as a weight-loss treatment.
Saxagliptin generally has little effect on body weight.
Any weight-related benefits should be considered secondary to its main purpose of improving blood sugar control.
Does Qtern protect the heart and kidneys?
Dapagliflozin, when prescribed separately, has established benefits for certain patients with heart failure or chronic kidney disease.
However, Qtern itself is approved for improving blood sugar control.
Its saxagliptin component also carries a heart failure warning.
Therefore, the benefits of dapagliflozin alone should not automatically be applied to Qtern.
Patients with existing heart or kidney conditions may benefit from a different treatment selected specifically for those conditions.
How Should Qtern Be Taken and Monitored?
Qtern is an oral medicine generally taken once daily in the morning, with or without food. Treatment requires attention to kidney function, medication interactions, and blood sugar monitoring.
Patients should follow their prescription rather than selecting a dose independently.
What strengths are listed for Qtern?
The U.S. prescribing information describes two strengths:
5 mg dapagliflozin + 5 mg saxagliptin
10 mg dapagliflozin + 5 mg saxagliptin
The appropriate strength depends on the patient's previous treatment, response, kidney function, and other medical considerations.
Generic product availability may differ by strength.
Tablets should be swallowed whole rather than crushed, cut, or chewed.
Why does kidney function matter?
Kidney function affects whether Qtern can be used safely and effectively.
Doctors assess kidney function using a test reported as estimated glomerular filtration rate, or eGFR.
The U.S. Qtern prescribing information states that the combination is contraindicated when eGFR is below 45 mL/min/1.73 m².
This means it should not be used when kidney function is below that level.
Kidney function should be assessed before starting treatment and periodically afterward.
What precautions matter during treatment?
Patients should discuss other diabetes medications, dehydration risks, and planned medical procedures with their clinician.
Important considerations include:
Insulin or sulfonylureas: Combining these with Qtern may increase the risk of low blood sugar.
Certain interacting medicines: Strong CYP3A4/5 inhibitors, including some antifungal medicines and antibiotics, should not be combined with Qtern.
Surgery: The label recommends withholding Qtern for at least three days before surgery or procedures involving prolonged fasting, when possible.
Pregnancy and breastfeeding: Qtern is not recommended during breastfeeding, and its use during pregnancy raises important safety concerns.
Patients should follow a clinician-directed treatment and sick-day plan rather than stopping or restarting medication independently.
What Are the Side Effects and Serious Risks of Qtern?
Qtern can cause common side effects and, less frequently, serious complications.
Some problems arise from increased glucose in urine, while others are associated with saxagliptin's effects on the body.
What are the common side effects?
Reported side effects include:
Upper respiratory tract infections
Headache
Changes in blood fat levels
Digestive discomfort
Increased urination
Not everyone experiences these effects.
However, persistent symptoms, painful urination, fever, or worsening discomfort should be assessed by a healthcare professional.
What is the risk of diabetic ketoacidosis?
Diabetic ketoacidosis occurs when excessive ketones make the blood dangerously acidic.
Ketones are substances produced when the body breaks down fat for energy.
SGLT2 inhibitors such as dapagliflozin can increase this risk in certain situations, including severe illness, prolonged fasting, dehydration, or insufficient insulin.
Importantly, ketoacidosis can occur even when blood sugar is not extremely high.
Warning signs include nausea, vomiting, abdominal pain, unusual tiredness, and difficulty breathing.
These symptoms require emergency medical assessment.
Why does Qtern carry a heart failure warning?
Saxagliptin has been associated with increased hospitalization for heart failure.
In a large cardiovascular study called SAVOR, hospitalization for heart failure occurred in 3.5% of patients receiving saxagliptin compared with 2.8% receiving placebo.
These findings concern saxagliptin and should not be interpreted as the exact risk for every Qtern user.
Doctors should carefully assess patients with a history of heart failure or reduced kidney function.
Other important but less common risks include pancreatitis, severe allergic reactions, serious genital infections, and blistering skin reactions.
Qtern can improve blood sugar control by combining two medications, but better glucose numbers do not automatically make it the best treatment for every patient. Kidney function, heart failure risk, infection history, and other diabetes medicines are essential considerations when deciding whether the combination is appropriate.
Who Should Avoid Qtern or Consider Another Diabetes Treatment?
Qtern is not suitable for everyone with type 2 diabetes.
A healthcare professional should review existing medical conditions before deciding whether the benefits outweigh the risks.
Who should not use Qtern?
According to U.S. prescribing information, Qtern is contraindicated in patients with:
eGFR below 45 mL/min/1.73 m²
End-stage kidney disease or dialysis treatment
A history of serious allergic reactions to dapagliflozin or saxagliptin
It is also not recommended for improving blood sugar control in people with type 1 diabetes.
Patients with heart failure, recurrent infections, pancreatitis concerns, or increased dehydration risk require additional assessment.
Are other diabetes medicines sometimes more appropriate?
Yes. Treatment selection depends on more than blood sugar alone.
For example, a clinician may consider metformin, another SGLT2 inhibitor, a GLP-1-based medicine, insulin, or another approved treatment depending on the patient's needs.
Some medications have demonstrated benefits for particular heart and kidney conditions.
Patients should discuss their HbA1c target, medical history, treatment costs, and long-term health goals before changing medicines.
When Should You Seek Medical Attention While Taking Qtern?
Certain symptoms during Qtern treatment may indicate complications that need urgent evaluation.
Recognizing these signs early is especially important for patients with diabetes, kidney problems, or existing heart disease.
Which warning signs need urgent attention?
Important Qtern-related warning signs, possible complications, and when to seek medical care.
Symptoms | Possible concern | Recommended action |
Burning urination or genital itching | Urinary or genital infection | Contact a healthcare professional promptly |
Fever with back or side pain | Possible kidney infection | Seek urgent medical care |
Vomiting, abdominal pain, or unusual breathing | Possible diabetic ketoacidosis | Seek emergency medical care |
Severe persistent upper abdominal pain | Possible pancreatitis | Stop Qtern and seek urgent assessment |
Breathlessness, ankle swelling, or rapid weight gain | Possible heart failure | Seek prompt medical evaluation |
Severe dizziness, fainting, or reduced urination | Dehydration or kidney-related complication | Seek urgent medical care |
Pain and swelling around the genitals with fever | Possible rare serious tissue infection | Seek emergency medical care |
Facial swelling or breathing difficulty | Serious allergic reaction | Seek emergency medical care |
Patients should also contact their diabetes care team if blood sugar levels become difficult to control or if illness prevents normal eating and drinking.
Do not double doses, combine diabetes medicines independently, or ignore symptoms suggesting ketoacidosis.
Conclusion
Qtern (dapagliflozin + saxagliptin) can help improve blood sugar control in suitable adults with type 2 diabetes. Its two ingredients work through different mechanisms, but treatment requires careful attention to kidney function, dehydration, infections, ketoacidosis, and heart failure concerns. Although the original Qtern brand was discontinued in the United States, FDA-approved generic combinations are available, subject to pharmacy supply.
If you are considering this combination or already taking it, discuss your HbA1c results, kidney health, other medications, and treatment goals with a qualified healthcare professional. Do not change treatment independently, and seek urgent medical care for serious warning signs.
Frequently Asked Questions
1. What is Qtern used for in type 2 diabetes?
Qtern is used alongside diet and exercise to improve blood sugar control in adults with type 2 diabetes. It combines dapagliflozin, which increases glucose removal through urine, and saxagliptin, which supports the body's natural insulin response.
2. Is Qtern the same as Farxiga?
No. Qtern contains dapagliflozin and saxagliptin, while Farxiga contains dapagliflozin alone. Their approved uses and safety considerations are not identical. A healthcare professional should determine which medication is appropriate based on your health conditions.
3. Can Qtern cause urinary tract infections?
Yes. Dapagliflozin increases glucose in urine, which can contribute to urinary and genital infections. Symptoms such as burning urination, genital irritation, or discomfort should be reported. Fever with back or side pain requires urgent medical assessment.
4. Is Qtern safe for people with kidney problems?
Qtern is not suitable for everyone with kidney disease. U.S. prescribing information contraindicates the combination when eGFR is below 45 mL/min/1.73 m². Kidney function should be checked before treatment and monitored afterward.
5. Does Qtern cause weight loss or low blood sugar?
Some patients experience modest weight reduction from dapagliflozin, but Qtern is not approved for weight loss. Low blood sugar is more likely when Qtern is combined with insulin or sulfonylureas. Medication selection and monitoring should be individualized.
6. Is Qtern discontinued in the United States?
The original Qtern brand is listed as discontinued, but the FDA determined it was not withdrawn for safety or effectiveness reasons. Generic dapagliflozin-saxagliptin combinations received FDA approval in April 2026. Pharmacy availability may vary.

.png)



Comments